DHFR and acute lymphoblastic leukemia: We previously reported a significant under-representation of DHFR and MTHFR gene variants among adult ALL and non-Hodgkin’s lymphoma in combined double carrier status, deserving increased drug-related toxicity and reduced survival to the polymorphic condition [15,16,17,18].